Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside
Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[64363-77-5]
UNSPSC
12352005
Hazard Statement
H302
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/methyl-2-3-5-tri-o-benzyl-d-ribofuranoside.html
Solubility
10 mM in DMSO
Smiles
COC(O[C@@H]1COCC2=CC=CC=C2)[C@H](OCC3=CC=CC=C3)[C@@H]1OCC4=CC=CC=C4
Molecular Formula
C27H30O5
Molecular Weight
434.52
Precautions
P264-P270-P330-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
DEFB109P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
PRMT7 (Protein Arginine N-methyltransferase 7, PRMT-7, KIAA1933, Protein Arginine N-methyltransferase 7, FLJ10640) (MaxLight 750) discontinued
MAD2L1BP Recombinant Antibody, PerCP-Cy5.5 Conjugated
